These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency]. Sartorio A, Conti A, Monzani M, Ferrero S, Biella O, Casati G, Faglia G. Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895 [Abstract] [Full Text] [Related]
24. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial. Sneppen SB, Hoeck HC, Kollerup G, Sørensen OH, Laurberg P, Feldt-Rasmussen U. Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427 [Abstract] [Full Text] [Related]
25. Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies. Abrahamsen B, Hangaard J, Horn HC, Hansen TB, Gregersen G, Hansen-Nord M, Vahl N, Junker P, Andersen M, Hagen C. Clin Endocrinol (Oxf); 2002 Aug; 57(2):273-81. PubMed ID: 12153608 [Abstract] [Full Text] [Related]
28. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults. Rodríguez-Arnao J, James I, Jabbar A, Trainer PJ, Perrett D, Besser GM, Ross RJ. Clin Endocrinol (Oxf); 1998 Apr; 48(4):455-62. PubMed ID: 9640412 [Abstract] [Full Text] [Related]
31. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Johannsson G, Rosén T, Bosaeus I, Sjöström L, Bengtsson BA. J Clin Endocrinol Metab; 1996 Aug; 81(8):2865-73. PubMed ID: 8768843 [Abstract] [Full Text] [Related]
32. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP. Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789 [Abstract] [Full Text] [Related]
33. [The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men]. Kozakowski J, Papierska L, Krassowski J, Zgliczyński S. Pol Arch Med Wewn; 1998 Oct; 100(4):306-12. PubMed ID: 10335039 [Abstract] [Full Text] [Related]
36. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A. J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530 [Abstract] [Full Text] [Related]
37. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents. Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G. Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973 [Abstract] [Full Text] [Related]
40. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Rahim A, Holmes SJ, Adams JE, Shalet SM. Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]